155 related articles for article (PubMed ID: 38352847)
1. Novel Fused Triazole Compounds as RIPK1 Inhibitors for Treating Neurodegenerative, Autoimmune, and Inflammatory Diseases.
Sabnis RW
ACS Med Chem Lett; 2024 Feb; 15(2):177-178. PubMed ID: 38352847
[TBL] [Abstract][Full Text] [Related]
2. Novel Fused Pyrazole Amide Analogs as Glucosylceramide Synthase Inhibitors for Treating Lysosomal Storage Diseases, Neurodegenerative Diseases, Cystic Diseases, and Cancer.
Sabnis RW
ACS Med Chem Lett; 2023 Dec; 14(12):1621-1622. PubMed ID: 38116443
[TBL] [Abstract][Full Text] [Related]
3. Fused Pyrazole Urea Analogs as Glucosylceramide Synthase Inhibitors for Treating Diseases.
Sabnis RW
ACS Med Chem Lett; 2023 Aug; 14(8):1031-1032. PubMed ID: 37583817
[TBL] [Abstract][Full Text] [Related]
4. Novel Isoxazolidines as RIPK1 Inhibitors for Treating Alzheimer's Disease, Multiple Sclerosis, and Amyotrophic Lateral Sclerosis.
Sabnis RW
ACS Med Chem Lett; 2024 Apr; 15(4):447-448. PubMed ID: 38628797
[TBL] [Abstract][Full Text] [Related]
5. Novel Tyrosine Kinase 2 Inhibitors for Treating Autoimmune and Inflammatory Diseases.
Sabnis RW
ACS Med Chem Lett; 2024 Jun; 15(6):769-770. PubMed ID: 38894908
[TBL] [Abstract][Full Text] [Related]
6. TYK2 Inhibitors for Treating Autoimmune and Inflammatory Diseases.
Sabnis RW
ACS Med Chem Lett; 2024 Mar; 15(3):320-321. PubMed ID: 38505839
[TBL] [Abstract][Full Text] [Related]
7. Pyrrolidinone Derivatives as NIK Inhibitors for Treating Inflammatory and Autoimmune Diseases.
Sabnis RW
ACS Med Chem Lett; 2024 Mar; 15(3):322-323. PubMed ID: 38505855
[TBL] [Abstract][Full Text] [Related]
8. Pyrrolidinone Derivatives as NIK Inhibitors for Treating Autoimmune and Inflammatory Diseases.
Sabnis RW
ACS Med Chem Lett; 2024 May; 15(5):581-582. PubMed ID: 38746901
[TBL] [Abstract][Full Text] [Related]
9. Novel Pyrido[3,2-
Sabnis RW
ACS Med Chem Lett; 2023 Dec; 14(12):1627-1628. PubMed ID: 38116408
[TBL] [Abstract][Full Text] [Related]
10. Novel Tetrahydropyrido[3,4-
Sabnis RW
ACS Med Chem Lett; 2024 Mar; 15(3):318-319. PubMed ID: 38505843
[TBL] [Abstract][Full Text] [Related]
11. Novel Thienopyrrole Compounds for Treating Autoimmune Diseases and Inflammatory Conditions.
Sabnis RW
ACS Med Chem Lett; 2023 May; 14(5):549-550. PubMed ID: 37197455
[TBL] [Abstract][Full Text] [Related]
12. Fused Bicyclic Heteroaryl Compounds as NLRP3 Inhibitors for Treating Asthma or COPD.
Sabnis RW
ACS Med Chem Lett; 2023 Jul; 14(7):895-896. PubMed ID: 37465294
[TBL] [Abstract][Full Text] [Related]
13. Boron-Containing Pyrazole Compounds as JAK Inhibitors for Treating Inflammation, Autoimmune Diseases, and Cancer.
Sabnis RW
ACS Med Chem Lett; 2022 Oct; 13(10):1554-1555. PubMed ID: 36267133
[TBL] [Abstract][Full Text] [Related]
14. Novel IRAK4 Inhibitors for Treating Asthma, COPD, Cancer, Autoinflammatory Diseases, and Autoimmune Diseases.
Sabnis RW
ACS Med Chem Lett; 2023 Dec; 14(12):1617-1618. PubMed ID: 38116447
[TBL] [Abstract][Full Text] [Related]
15. Novel Compounds as S1P5 Modulators for Treating Neurodegenerative Diseases.
Sabnis RW; Sabnis AR
ACS Med Chem Lett; 2024 Jun; 15(6):750-751. PubMed ID: 38894913
[TBL] [Abstract][Full Text] [Related]
16. Novel Imidazotriazine Derivatives as IL-17 Modulators for Treating Inflammatory and Autoimmune Disorders.
Sabnis RW
ACS Med Chem Lett; 2023 May; 14(5):553-554. PubMed ID: 37197462
[TBL] [Abstract][Full Text] [Related]
17. Novel RIPK1 Inhibitors for Treating Neurodegenerative, Autoimmune, and Inflammatory Diseases.
Sabnis RW
ACS Med Chem Lett; 2022 Apr; 13(4):524-525. PubMed ID: 35450352
[No Abstract] [Full Text] [Related]
18. Carboxylic Acid-Containing Indanyl Compounds as S1P5 Modulators for Treating Neurodegenerative Diseases.
Sabnis RW; Sabnis AR
ACS Med Chem Lett; 2023 Aug; 14(8):1033-1034. PubMed ID: 37583826
[TBL] [Abstract][Full Text] [Related]
19. Novel Myeloperoxidase Inhibitors for Treating Multiple Diseases.
Sabnis RW
ACS Med Chem Lett; 2024 May; 15(5):569-570. PubMed ID: 38746891
[TBL] [Abstract][Full Text] [Related]
20. Nitrogen-Containing 2,3-Dihydroquinazolinone Compounds as Na
Sabnis RW
ACS Med Chem Lett; 2023 Jul; 14(7):893-894. PubMed ID: 37465303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
